Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • My Collection
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Interface
  4. AI Interpretation Software for Cellular Images

AI Interpretation Software for Cellular Images

Deep learning tools that analyze microscope images to detect cell structures, abnormalities, and disease markers
Back to InterfaceView interactive version

AI interpretation software for cellular images uses deep learning and computer vision algorithms to automatically analyze microscopic images of cells, identifying structures, abnormalities, and patterns that would typically require expert pathologists or researchers to identify manually. The software can detect and classify various cell types, identify disease markers, count cells, measure cellular features, and recognize morphological changes. The AI algorithms are trained on vast datasets of annotated cellular images, enabling them to recognize subtle patterns and abnormalities with high accuracy.

The technology accelerates research and diagnostics by providing rapid, consistent analysis of cellular images, reducing the time and expertise required for manual examination. The software can process large volumes of images quickly, identify rare events that might be missed in manual review, and provide quantitative measurements that are difficult to obtain manually. Applications include medical diagnostics (identifying cancer cells, blood disorders, infections), drug discovery (analyzing cellular responses to compounds), research (studying cellular processes and disease mechanisms), and quality control in biomanufacturing. The technology enhances the capabilities of researchers and clinicians, enabling more efficient analysis, earlier detection of issues, and more comprehensive examination of cellular samples.

Technology Readiness Level
4/9Formative
Impact
3/5Medium
Investment
3/5Medium
Category
Software

Related Organizations

Paige logo
Paige

United States · Startup

98%

Provides FDA-cleared AI software for computational pathology, focusing on cancer diagnostics.

Developer
PathAI logo
PathAI

United States · Company

98%

Develops AI-powered research tools and services for pathology to improve the accuracy of diagnosis and treatment.

Developer
Ibex Medical Analytics logo
Ibex Medical Analytics

Israel · Startup

95%

Develops AI-based cancer diagnostics software for pathology labs to detect cancer in biopsies.

Developer
Visiopharm logo
Visiopharm

Denmark · Company

92%

Provides precision pathology software using deep learning for tissue analysis and cellular phenotyping.

Developer
Aiforia Technologies logo
Aiforia Technologies

Finland · Company

90%

Provides cloud-based deep learning AI for image analysis in pathology and histology.

Developer
Indica Labs logo
Indica Labs

United States · Company

90%

Creators of HALO, a digital pathology image analysis platform that integrates AI for cell counting and tissue classification.

Developer
Proscia logo
Proscia

United States · Startup

88%

Develops the Concentriq digital pathology platform which hosts AI applications for image interpretation.

Developer
Leica Biosystems logo
Leica Biosystems

Germany · Company

85%

A global leader in pathology workflow solutions, integrating AI analysis tools into their Aperio digital pathology systems.

Developer
Owkin logo
Owkin

France · Startup

85%

A biotech company that uses federated learning to train AI models on distributed patient data without the data leaving hospitals.

Developer
Roche Tissue Diagnostics logo
Roche Tissue Diagnostics

Switzerland · Company

85%

Develops companion diagnostics and digital pathology algorithms (uPath) for cellular analysis.

Developer

Supporting Evidence

Article

Aivia AI Image Analysis Software

Leica Microsystems · Apr 22, 2025

Aivia 15 empowers scientists with intuitive tools for powerful insights, no AI expertise needed. Simply paint on cells of interest for deep-learning powered detection (modified from Cellpose).

Support 95%Confidence 99%

Paper

STHD: probabilistic cell typing of single spots in whole transcriptome spatial data with high definition

Genome Biology · Jul 18, 2025

We present STHD for probabilistic cell typing of single spots in whole-transcriptome spatial transcriptomics with high definition. With a machine learning model... STHD accurately predicts cell type identities of subcellular spots.

Support 92%Confidence 75%

Article

Aivia 15: Deep-learning powered Segment by Example

Leica Microsystems · Apr 22, 2025

Aivia 15 introduces 'Segment by Example', allowing scientists to paint on cells to deploy a generalist deep learning model (modified from Cellpose) for accurate 2D and 3D segmentation without coding.

Support 92%Confidence 70%

Connections

Hardware
AI-Powered Camera Systems

Machine learning algorithms that enhance camera image quality in fog, low light, and adverse weather

Technology Readiness Level
5/9
Impact
3/5
Investment
3/5
Software
Software
AI Visual Inspection Platforms

Computer vision systems that detect product defects and quality issues in manufacturing

Technology Readiness Level
4/9
Impact
3/5
Investment
3/5
Applications
On-Device AI Pill Counter

Computer vision systems that count pills locally without cloud processing

Technology Readiness Level
5/9
Impact
3/5
Investment
3/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions